Clinical characteristics of coronavirus disease 2019 patients with diarrhea in Daegu
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: Coronavirus disease 2019 (COVID-19) can reportedly cause gastrointestinal symptoms. Therefore, we investigated the clinical characteristics of COVID-19 patients with diarrhea. Methods: We included 118 COVID-19 patients admitted to a single hospital from February 20 to March 31, 2020. Medical records with clinical characteristics, laboratory data, treatment course, and clinical outcomes were compared based on the presence or absence of diarrhea. Prognostic factors for disease severity and mortality in COVID-19 were also assessed. Results: Among patients, 54 (45.8%) had diarrhea, whereas seven (5.9%) had only diarrhea. The median age of patients with diarrhea was 59 years (44 to 64), and 22 (40.7%) were male. Systemic steroid use, intensive care unit admission, septic shock, and acute respiratory distress syndrome were less frequent in the diarrhea group than in the non-diarrhea group. No significant differences were observed in total hospital stay and mortality between groups. On multivariate analysis, age (odds ratio [OR], 1.06; 95% confidence interval [CI], 1.01 to 1.12; p = 0.044), diabetes (OR, 3.00; 95% CI, 1.25 to 20.47; p = 0.042), and dyspnea (OR, 41.19; 95% CI, 6.60 to 823.16; p < 0.001) were independent risk factors for septic shock. On Cox regression analysis, diabetes (hazard ratio [HR], 4.82; 95% CI, 0.89 to 26.03; p = 0.043) and chronic obstructive pulmonary disease (HR, 16.58; 95% CI, 3.10 to 88.70; p = 0.044) were risk factors for mortality. Conclusions: Diarrhea was present in 45.8% of patients and was a common symptom of COVID-19. Although patients with diarrhea showed less severe clinical features, diarrhea was not associated with disease severity or mortality.
Abstract
Background/Aims: Coronavirus disease 2019 (COVID-19) can reportedly cause gastrointestinal symptoms. Therefore, we investigated the clinical characteristics of COVID-19 patients with diarrhea. Methods: We included 118 COVID-19 patients admitted to a single hospital from February 20 to March 31, 2020. Medical records with clinical characteristics, laboratory data, treatment course, and clinical outcomes were compared based on the presence or absence of diarrhea. Prognostic factors for disease severity and mortality in COVID-19 were also assessed. Results: Among patients, 54 (45.8%) had diarrhea, whereas seven (5.9%) had only diarrhea. The median age of patients with diarrhea was 59 years (44 to 64), and 22 (40.7%) were male. Systemic steroid use, intensive care unit admission, septic shock, and acute respiratory distress syndrome were less frequent in the diarrhea group than in the non-diarrhea group. No significant differences were observed in total hospital stay and mortality between groups. On multivariate analysis, age (odds ratio [OR], 1.06; 95% confidence interval [CI], 1.01 to 1.12; p = 0.044), diabetes (OR, 3.00; 95% CI, 1.25 to 20.47; p = 0.042), and dyspnea (OR, 41.19; 95% CI, 6.60 to 823.16; p < 0.001) were independent risk factors for septic shock. On Cox regression analysis, diabetes (hazard ratio [HR], 4.82; 95% CI, 0.89 to 26.03; p = 0.043) and chronic obstructive pulmonary disease (HR, 16.58; 95% CI, 3.10 to 88.70; p = 0.044) were risk factors for mortality. Conclusions: Diarrhea was present in 45.8% of patients and was a common symptom of COVID-19. Although patients with diarrhea showed less severe clinical features, diarrhea was not associated with disease severity or mortality.
참고문헌 (17)
- Gu J, "COVID-19 : gastrointestinal manifestations and potential fecal-oral transmission", Gastroenterology, 158, pp.1518~1519 (2020)
- Khot WY, "The 2019 novel coronavirus outbreak : a global threat", J Assoc Physicians India, 68, pp.67~71 (2020)
- Legido-Quigley H, "Are high-performing health systems resilient against the COVID-19epidemic", Lancet, 395, pp.848~850 (2020)
- Wang P, "The SARS-CoV-2 outbreak : diagnosis, infection prevention, and public perception", Clin Chem, 66, pp.644~651 (2020)
- Phelan AL, "The novel coronavirus originating in Wuhan, China : challenges for global health governance", JAMA, 323, pp.709~710 (2020)
- Pan L, "Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China : a descriptive, cross-sectional, multicenter study", Am J Gastroenterol, 115, pp.766~773 (2020)
- Gao QY, "2019 Novel coronavirus infection and gastrointestinal tract", J Dig Dis, 21, pp.125~126 (2020)
- Bone RC, "Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP", SCCM Consensus Conference Committee. American College of Chest Physicians, Chest, pp.1992, 101[DOI]
- "Clinical management of severe acute respiratory infection (SARI) when COVID-19disease is suspected: interim guidance" (2020)[URL]
- Stevens PE, "Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline", Ann Intern Med, 158, pp.825~830 (2013)
- Lu R, "Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding", Lancet, 395, pp.565~574 (2020)
- Zhou P, "A pneumonia outbreak associated with a new coronavirus of probable bat origin", Nature, 579, pp.270~273 (2020)
- Zhang C, "Liver injury in COVID-19 : management and challenges", Lancet Gastroenterol Hepatol, 5, pp.428~430 (2020)
- Zhang H, "The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes", BioRxiv (2019)[DOI]
- Li M, "Symbiotic gut microbes modulate human metabolic phenotypes", Proc Natl Acad Sci U S A, 105, pp.2117~2122 (2008)
- Tang A, "Detection of novel coronavirus by RT-PCR in stool specimen from asymptomatic child, China", Emerg Infect Dis, 26, pp.1337~1339 (2020)
- Xie C, "Comparison of different samples for 2019 novel coronavirus detection by nucleic acid amplification tests", Int J Infect Dis, 93, pp.264~267 (2020)